市场洞察和分析师观点：
淋巴水肿是指因富含蛋白质的液体积聚而引起的组织肿胀，这些液体通过身体的淋巴管排出系统。它最常影响手臂或腿部，但也可能发生在胸壁、腹部、颈部和生殖器。淋巴结是淋巴系统的重要组成部分。淋巴水肿很大程度上是由几种癌症治疗的结果引起的。这些包括前列腺癌、头颈癌和盆腔癌，例如膀胱癌、睾丸癌、卵巢癌、子宫癌或子宫颈癌，以及淋巴瘤和黑色素瘤。肿胀可能发生在接受治疗的身体部位。例如，通过放射或手术治疗腹部或骨盆肿瘤可能会导致腹股沟、生殖器、腹部和一条腿或双腿肿胀。头颈癌的治疗可能会导致面部、眼睛或口腔肿胀。
增长动力：
淋巴丝虫病的患病率
淋巴丝虫病 (LF) 仍然是一个重大的公共卫生挑战印度。这种媒介传播的寄生虫病会带来极大的痛苦，并使身体部位变形，导致严重残疾，从而导致称为象皮病的病症。全球 40% 以上的 LF 病例发生在印度，对该国构成重大威胁。
印度约有 6.4 亿人面临感染该疾病的风险。印度 20 个邦/联邦直辖区的 336 个地区均报告有 LF。印度 90% 的 LF 负担由八个热带邦承担，包括北方邦、比哈尔邦、贾坎德邦、西孟加拉邦、恰蒂斯加尔邦、马哈拉施特拉邦、奥里萨邦和中央邦。
根据国家疾病模型联盟的统计，共有 525,440 例2021 年印度报告了淋巴水肿病例。大多数淋巴水肿病例来自比哈尔邦、北方邦、奥里萨邦和特伦甘纳邦。此外，据《印度时报》报道，2023年2月，艾哈迈达巴德发现了四例淋巴水肿病例。此外，2022年1月至2022年4月，卡纳塔克邦图马库鲁地区发现了16例淋巴水肿病例。其中，感染者主要是来自卡纳塔克邦比哈尔邦、奥里萨邦、北方邦和维贾亚普拉地区的外来务工人员。
，淋巴丝虫病数量的不断增加最终推动了印度淋巴水肿治疗市场的发展。
癌症治疗的副作用
癌症及其治疗方法，例如手术和放射治疗，有时可能会改变、阻止或中断淋巴丝虫的流动淋巴液流经淋巴系统。当淋巴液积聚导致水肿时，称为淋巴水肿。这种液体的异常聚集会导致身体特定部位肿胀，最常见的是手臂或腿部。如果不治疗，淋巴水肿可能会导致受影响肢体的功能和活动能力下降、皮肤问题、疼痛和不适以及其他并发症。富含蛋白质的淋巴液积聚可能导致肿胀加剧、组织硬化和感染。
淋巴水肿通常与乳腺癌的副作用有关。乳腺癌患者主要面临发生淋巴水肿的风险，因为乳腺癌手术、放射治疗或癌症治疗组合可能会切除或损坏乳房附近的腋窝淋巴结。前列腺癌、妇科癌症、淋巴瘤、黑色素瘤或其他癌症的治疗也可能导致淋巴水肿。淋巴结切除或受损越多，发生淋巴水肿的风险就越高。
根据 Globocan 2020 统计数据，印度发现近 178,361 例病例，约 90,408 人死于该病。乳腺癌治疗最常见的并发症是淋巴水肿。此外，根据印度医学研究委员会非传染性疾病部门协调的共识 2022，前列腺癌似乎是印度男性中一个日益严重的问题。近年来，前列腺癌的发病率一直在稳步上升。根据 NCDIR 数据库，前列腺癌位居班加罗尔、德里、博帕尔和孟买城市癌症登记处的十大癌症之列。 2016 年，印度报告的前列腺癌病例为 37,416 例，到 2020 年增加到 41,532 例。据同一来源称，到 2025 年，前列腺癌发病率预计将增加到 47,000 例以上。
因此，癌症发病率不断上升特别是乳腺癌和前列腺癌，促使放射治疗和手术治疗推动了印度的淋巴水肿治疗市场。
报告细分和范围：
“印度淋巴水肿治疗市场”在此基础上进行细分状况类型、治疗类型和最终用户。根据病情类型，市场分为原发性淋巴水肿和继发性淋巴水肿。就治疗类型而言，印度淋巴水肿治疗市场分为加压装置和绷带、药物治疗、生理手术、减瘤手术等。生理手术部分进一步分为淋巴静脉吻合术（LVA）和血管化淋巴结转移（VLNT）。减瘤手术又细分为吸脂术、减瘤手术等。根据最终用户，市场分为医院、诊所、临床研究组织 (CRO) 等。
细分分析：
印度淋巴水肿治疗市场按病情类型分为原发性淋巴水肿和继发性淋巴水肿淋巴水肿。继发性淋巴水肿细分市场在 2022 年占据了更大的市场份额。预计原发性淋巴水肿细分市场在 2022 年至 2030 年期间将实现更高的复合年增长率。继发性淋巴水肿的大部分通常归因于癌症相关治疗，这是继发性淋巴水肿的主要原因。原发性淋巴水肿是一种罕见的慢性病理，与淋巴系统的体质异常有关。例如，Frontiers SA 报告指出，原发性淋巴水肿可能在 35 岁时出现，也称为迟发性淋巴水肿。此外，原发性淋巴水肿的发病率很低，全世界有十分之一的人受到影响。原发性淋巴水肿也与获得性淋巴水肿密切相关，并且具有导致原发性淋巴水肿的基因突变。例如，患有获得性淋巴水肿的乳腺癌患者在引起原发性淋巴水肿的相同基因中具有较高的遗传变异，称为单核苷酸多态性（SNP）。这些因素在分析期间对该细分市场的整体增长产生积极影响。
印度淋巴水肿治疗市场，按病情类型 - 2022 年和 2030 年
根据治疗类型，印度淋巴水肿治疗市场细分为加压设备和绷带，药物治疗、生理手术、减瘤手术等。生理手术部分进一步分为淋巴静脉吻合术（LVA）和血管化淋巴结转移（VLNT）。减瘤手术又细分为吸脂术、减瘤手术等。 2022 年，压缩设备和绷带细分市场占据最大市场份额。预计生理手术细分市场将在 2022 年至 2030 年期间实现最高的复合年增长率。这主要归功于通过 LVA 和 VLNT 对淋巴水肿患者进行了适当的治疗程序。这两种手术是淋巴水肿患者的适当治疗选择。淋巴水肿治疗的手术技术分为两部分：生理治疗和消融治疗。生理外科技术是显微外科手术，通过淋巴管与静脉系统的吻合或在消融治疗区域合并功能性淋巴结，促进淋巴液的生理引流。根据 NCBI 报告，生理治疗在淋巴水肿的早期阶段最为有效。添加消融疗法还可以为晚期淋巴水肿提供有效的治疗选择。
根据最终用户，印度淋巴水肿治疗市场分为医院、诊所、临床研究组织 (CRO) 等。医院细分市场在 2022 年占据最大市场份额，预计 2022 年至 2030 年市场复合年增长率最高，因为许多淋巴水肿手术在医院进行，并且知名企业针对医院推出了创新产品，以最大限度地提高患者的治疗效果。利用率。 2020年9月，Paul Hartmann与印度阿波罗医院集团和华西医院合作，重点关注伤口护理诊所和救护车的手术、医疗培训以及产品和服务。这些战略步骤使公司能够扩大其在发达市场的产品组合。医院部门在整个淋巴水肿治疗市场中占据最大份额。这主要是由于医院越来越多地采用微创手术以及采用先进的成像方式来治疗淋巴水肿。此外，医院还进行手术治疗淋巴水肿。例如，在密歇根大学，整形外科医生和职业治疗师共同努力，为患病患者确定最佳治疗方案。例如，宾夕法尼亚大学医学报告指出，约 60% 在医院接受淋巴水肿治疗的患者有明显改善。此外，支持医院淋巴治疗的优惠报销政策支持了整体市场的增长。例如，人们日益认识到淋巴水肿是肿瘤手术后一种昂贵的、可预防的并发症，消除了患者、医院和医疗保健系统之间治疗性和预防性手术的医疗保险范围之间的障碍。
国家分析：
由于放射治疗会直接损伤淋巴管，进而降低淋巴管的承载能力，从而增加淋巴水肿的风险。根据国家生物技术信息中心 (NCBI) 发表的一篇文章“2022 年癌症发病率估计和 2025 年预测：印度国家癌症登记计划的结果”，印度的癌症病例数估计为 1,461,427 例。 2022 年。在印度，九分之一的人可能在一生中患上癌症。肺癌和乳腺癌分别是男性和女性的主要癌症部位。根据 Globocan 2020 报告，乳腺癌是印度最常见的癌症。 2020 年，印度有 178,361 例（13.5%）乳腺癌病例。这可能需要印度进行放射治疗。根据同一份报告，肺癌新发病例为 72,510 例（5.5%），唇癌和口腔癌新发病例为 135,929 例（10.3%），宫颈癌新发病例为 123,907 例（9.4%），结直肠癌新发病例为 65,358 例（4.9%）。印度报告了 748,348 例（56.5%）其他癌症病例。因此，越来越多地使用放射疗法来治疗癌症以及癌症的高患病率正在推动印度淋巴水肿治疗市场的增长。
心血管疾病 (CVD) 和中风等慢性病的患病率、老年人口的增加、生活方式的改善印度的疾病和肥胖率高是推动市场增长的其他因素。根据世界心脏联合会的数据，CVD 占印度成人死亡总数的 60%。吸烟成瘾和饮酒量增加是导致印度成年人（即近 15% 人口）出现 CVD 相关风险的因素之一。据印度中风协会称，印度每年有 180 万人患有中风。此外，人们对中风的认识较低，农村地区的人们对神经血管疾病的认识不高。淋巴水肿也可能是心脏劳损的结果。当心脏必须更加努力地泵送和循环全身（包括受影响的肢体）的血液时，就会发生这种情况。因此，预计这些因素将刺激该地区的印度淋巴水肿治疗市场。
行业发展和未来机遇：
印度淋巴水肿治疗市场主要参与者采取的各种举措如下：
KOB GmbH 在 2022 年 MEDICA 贸易博览会上推出了两款产品。通过这款 2 组件系统，该公司扩大了压缩绷带的产品组合。当需要较低的压缩压力时，使用 VisioCompress2 Lite。与经过验证的 VisioCompress2 多层系统一样，VisioCompress2 Lite 由填充物和永久弹性无纺绷带组成。竞争格局和主要公司：
Essity AB、Lympha Press USA Ltd、AIROS Medical Inc、3M Co、Bio Compression Systems Inc、Lohmann & Rauscher GmbH & Co KG、Huntleigh Healthcare Ltd、Dynamic Techno Medicals Pvt Ltd、Medi GmbH & Co KG、Datt Mediproducts Pvt Ltd、Smith & Nephew Plc、SIGVARIS Management AG 和 Tactile Systems Technology Inc 是印度淋巴水肿治疗市场的著名公司。这些公司专注于新技术、现有产品的进步以及地域扩张，以满足全球不断增长的消费者需求。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Companies operating in the market are Essity AB, Lympha Press USA Ltd, AIROS Medical Inc, 3M Co, Bio Compression Systems Inc, Lohmann & Rauscher GmbH & Co KG, Huntleigh Healthcare Ltd, Dynamic Techno Medicals Pvt Ltd, Medi GmbH & Co KG, Datt Mediproducts Pvt Ltd, Smith & Nephew Plc, SIGVARIS Management AG, and Tactile Systems Technology Inc.
The “India Lymphedema Treatment Market” is segmented based on condition type, treatment type, and end user. Based on treatment type, the global lymphedema treatment market is segmented into compression devices and bandaging, drug therapy, physiological procedure, debulking procedure, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). The debulking procedures segment is sub-segmented into liposuction, surgical debulking, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is expected to register the highest CAGR in the market during 2022–2030. This is mainly due to the appropriate treatment procedures performed on lymphedema patients through LVA and VLNT. These two procedures are appropriate treatment options for patients suffering from lymphedema.
Prevalence of lymphatic filariasis, adverse effects of cancer treatment, and growing awareness of lymphedema are driving the market growth. However, the high cost of lymphedema treatment is hampering the market growth.
Based on condition type, the global lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held the largest share of the market in 2022. The primary lymphedema segment is anticipated to register a higher CAGR during 2022–2030. Secondary lymphedema's significant share is usually attributed to cancer-related treatment, which is a prominent cause of secondary lymphedema.
Lymphedema refers to tissue swelling caused by an accumulation of protein-rich fluid, which is drained through the body's lymphatic system. It most commonly affects the arms or legs but can also occur in the chest wall, abdomen, neck, and genitals. Lymph nodes are an essential part of the lymphatic system. Lymphedema is largely caused due to the consequence of several cancer treatments. These include prostate, head and neck, and pelvic cancers such as those in bladder, testicles, ovaries, uterus, or cervix, along with lymphoma and melanoma. The swelling may occur on the part of the body that is treated. For instance, treating tumors in the belly or pelvis via radiation or surgery may cause swelling in the groin, genitals, belly, and one or both legs. Swelling in the face, eyes, or mouth can be caused by treatment for head & neck cancer.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - India Lymphedema Treatment Market
- Essity AB,
- Lympha Press USA Ltd
- AIROS Medical Inc
- 3M Co
- Bio Compression Systems Inc
- Lohmann & Rauscher GmbH & Co KG
- Huntleigh Healthcare Ltd
- Dynamic Techno Medicals Pvt Ltd
- Medi GmbH & Co KG
- Datt Mediproducts Pvt Ltd
- Smith & Nephew Plc
- SIGVARIS Management AG
- Tactile Systems Technology Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For